Indaptus Therapeutics, Inc.
INDP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $220,608 | $414,001 | $335,442 | $652,860 |
| - Cash | $5,787 | $13,362 | $9,627 | $39,132 |
| + Debt | $84 | $175 | $80 | $169 |
| Enterprise Value | $214,905 | $400,814 | $325,896 | $613,897 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$15,365 | -$16,377 | -$14,909 | -$7,728 |
| % Margin | – | – | – | – |
| Net Income | -$15,022 | -$15,423 | -$14,323 | -$7,711 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.61 | -1.84 | -1.73 | -1.89 |
| % Growth | 12.5% | -6.4% | 8.5% | – |
| Operating Cash Flow | -$12,323 | -$13,405 | -$13,078 | -$11,291 |
| Capital Expenditures | $0 | $0 | -$173 | -$4 |
| Free Cash Flow | -$12,323 | -$13,405 | -$13,251 | -$11,294 |